| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.15 | 1e-06 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | 0.15 | 1e-05 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.13 | 1e-05 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.12 | 4e-05 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.12 | 4e-05 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.12 | 5e-05 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | 0.15 | 6e-05 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | 0.13 | 9e-05 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.17 | 0.0001 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0001 |